Cobb Stuart's Form 4 filing
Neurogene Inc. (NGNE) · filed Mar 17, 2026
- Accession no.
- 0001994301-26-000004
- Filed
- Mar 17, 2026
- Trade date
- Mar 13, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $141.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cobb StuartCIK 0001994301 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Common Stock | SSaleDisposed | −3,991 | $20.41 | −$81,456.31 | 33,303 | Direct | |
| Mar 13, 2026 | Common Stock | SSaleDisposed | −2,658 | $21.34 | −$56,721.72 | 30,645 | Direct | |
| Mar 13, 2026 | Common Stock | SSaleDisposed | −148 | $22.08 | −$3,267.84 | 30,497 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.